Attached files
file | filename |
---|---|
8-K - FORM 8-K - ATHENAHEALTH INC | b88654e8vk.htm |
EX-99.2 - EX-99.2 - ATHENAHEALTH INC | b88654exv99w2.htm |
Exhibit 99.1
athenahealth, Inc. Reports Third Quarter Fiscal Year 2011 Results
§ | 33% Revenue Growth Over Third Quarter of 2010 | ||
§ | GAAP Net Income of $5.3 Million, or $0.15 Per Diluted Share | ||
§ | Non-GAAP Adjusted Net Income of $8.7 Million, or $0.24 Per Diluted Share |
WATERTOWN,
MA October 20, 2011 athenahealth, Inc. (NASDAQ: ATHN) (the Company), a
leading provider of cloud-based practice management, electronic health record (EHR), patient
communication, and care coordination services to medical groups, today announced financial and
operational results for the third quarter of fiscal year 2011. The Company will conduct a
conference call tomorrow, Friday, October 21, 2011, at 8:00 a.m. Eastern Time to discuss these
results and managements outlook for future financial and operational performance.
Total revenue for the three months ended September 30, 2011 was $83.7 million, compared to $63.1
million in the same period last year, an increase of 33%.
During Q3, athenahealth made significant progress toward our vision of an information
infrastructure that makes health care work as it should, said Jonathan Bush, the Companys
Chairman, President, and Chief Executive Officer. Our cloud-based services continue to chip away
at inefficiency in the health care supply chain and to disrupt the legacy software model.
Bush continued, In keeping with our mission to be medical groups most trusted business service,
we set a new industry standard for transparency with our Meaningful Use performance dashboard,
exposing our clients performance across all measures in near real-time. Each update to this
dashboard illustrates the combined power of our cloud-based application and services model to
successfully guide clients through complex payment programs. We enhanced the power of this model by
completing the acquisition of Proxsys LLC and launching athenaCoordinator to enable hospitals and
other receivers of patient referrals to better coordinate care.
For the three months ended September 30, 2011, Non-GAAP Adjusted Gross Margin was 63.8%, up from
62.8% in the same period last year. Non-GAAP Adjusted EBITDA grew to $18.9 million, or 22.6% of
total revenue, from Non-GAAP Adjusted EBITDA of $14.6 million, or 23.0% of total revenue, in the
same period last year. For the three months ended September 30, 2011, GAAP net income was $5.3
million, or $0.15 per diluted share, and Non-GAAP Adjusted Net Income was $8.7 million, or $0.24
per diluted share. See Use of Non-GAAP Financial Measures below.
The growth we achieved during Q3 reflects strong market demand for our services, said Tim Adams,
the Companys Chief Financial Officer. It was a very productive quarter during which we leveraged
strong top line performance to invest in continued growth and innovation. As we approach the close
of 2011, we are updating our fiscal year 2011 guidance.
athenahealths revised fiscal year 2011 guidance is presented below:
athenahealths revised fiscal year 2011 guidance is presented below:
For the Fiscal Year Ending December 31, 2011 | ||
GAAP Total Revenue |
$320-325 million | |
Non-GAAP Adjusted Gross Margin |
63.0-63.5% | |
Non-GAAP Adjusted EBITDA |
$64-68 million | |
Non-GAAP Adjusted Net Income per Diluted Share |
$0.78-0.85 | |
GAAP Effective Tax Rate |
~42% |
Key metrics and milestones in the third quarter of fiscal year 2011 included the following:
| $1.9 billion in collections posted to client accounts in the third quarter of 2011, compared to $1.5 billion in the same quarter of 2010 | ||
| 39.7 average client Days in Accounts Receivable (DAR) in the third quarter of 2011, compared to 38.8 average client DAR in the same quarter of 2010 | ||
| 31,675 active medical providers using athenaCollector® at September 30, 2011, 22,477 of whom were physicians, compared to 26,317 providers and 18,573 physicians at September 30, 2010 | ||
| 5,849 active medical providers using athenaClinicals® at September 30, 2011, 4,202 of whom were physicians, compared to 2,818 providers and 1,992 physicians at September 30, 2010 | ||
| 4,117 active medical providers using athenaCommunicator® at September 30, 2011, 2,931 of whom were physicians, compared to 946 providers and 625 physicians at September 30, 2010 | ||
| Completed the acquisition of Proxsys LLC in an all-cash transaction on August 31, 2011 and launched the athenaCoordinator service offering |
As of September 30, 2011, the Company had cash, cash equivalents, short and long-term investments
of $122.2 million. The Company does not have any outstanding debt obligations. Subsequent to the
quarter ended September 30, 2011, athenahealth entered into a five-year $100 million revolving
credit facility. The Credit Agreement replaces a $15 million credit facility that expired September
30, 2011.
Use of Non-GAAP Financial Measures
In the Companys earnings releases, conference calls, slide presentations, and webcasts, the
Company may use or discuss non-GAAP financial measures as defined by SEC Regulation G. The GAAP
financial measure most directly comparable to each non-GAAP financial measure used or discussed,
and a reconciliation of the differences between each non-GAAP financial measure and the comparable
GAAP financial measure, are included in this press release after the condensed consolidated
financial statements. The Companys earnings press releases containing
2
such non-GAAP reconciliations can be found on the Investors section of the Companys web site at
http://www.athenahealth.com.
Conference Call Information
To participate in the Companys live conference call and webcast, please dial 800-447-0521 (or
847-413-3238 for international calls) using conference code No. 30770697, or visit the Investors
section of the Companys web site at www.athenahealth.com. A replay will be available for one week
following the conference call at 888-843-7419 (and 630-652-3042 for international calls) using
conference code No. 30770697. A webcast replay will also be archived on the Companys website.
About athenahealth
athenahealth, Inc. is a leading provider of cloud-based business services for physician
practices. athenahealths service offerings are based on proprietary web-native practice management
and electronic health record (EHR) software, a continuously updated payer knowledge-base,
integrated back-office service operations, automated and live patient communication services,
and the coordination of care among participants in the health care system. For more
information, please visit http://www.athenahealth.com/ or call (888) 652-8200.
Forward-Looking Statements
This press release contains forward-looking statements, which are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995, including statements reflecting
managements expectations for future financial and operational performance and operating
expenditures, expected growth and business outlook, statements regarding the expected benefits
resulting from the Proxsys LLC acquisition, the benefits of the Companys current service
offerings, and statements found under the Companys Reconciliation of Non-GAAP Financial Measures
section of this release. The forward-looking statements in this release do not constitute
guarantees of future performance. These statements are neither promises nor guarantees, and are
subject to a variety of risks and uncertainties, many of which are beyond the Companys control,
which could cause actual results to differ materially from those contemplated in these
forward-looking statements. In particular, the risks and uncertainties include, among other things:
the Companys fluctuating operating results; risks associated with the acquisition and integration
of companies and new technologies; the Companys variable sales and implementation cycles, which
may result in fluctuations in its quarterly results; risks associated with its expectations
regarding its ability to maintain profitability; the impact of increased sales and marketing
expenditures, including whether increased expansion in revenues is attained and whether impact on
margins and profitability is longer term than expected; changes in tax rates or exposure to
additional tax liabilities; the highly competitive industry in which the Company operates and the
relative immaturity of the market for its service offerings; and the evolving and complex
governmental and regulatory compliance environment in which the Company and its clients operate.
Existing and prospective investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof. The Company undertakes no
obligation to update or revise the information contained in this press release, whether as a result
of new information, future events or circumstances, or otherwise. For additional disclosure
regarding these and other risks faced by the Company, see the disclosures
3
contained in its public filings with the Securities and Exchange Commission, available on the
Investors section of the Companys website at http://www.athenahealth.com and on the SECs website
at http://www.sec.gov.
Contacts:
Jennifer Heizer (Investors)
Director, Investor Relations
athenahealth, Inc.
(617) 402-1322
investorrelations@athenahealth.com
Jennifer Heizer (Investors)
Director, Investor Relations
athenahealth, Inc.
(617) 402-1322
investorrelations@athenahealth.com
John Hallock (Media)
Director, Corporate Communications
athenahealth, Inc.
(617) 402-1428
media@athenahealth.com
Director, Corporate Communications
athenahealth, Inc.
(617) 402-1428
media@athenahealth.com
4
athenahealth, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands, except per share amounts)
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands, except per share amounts)
September | December | |||||||
30, 2011 | 31, 2010 | |||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 66,107 | $ | 35,944 | ||||
Short-term investments |
52,359 | 80,231 | ||||||
Accounts receivable net |
47,116 | 36,870 | ||||||
Deferred tax assets |
4,598 | 3,856 | ||||||
Prepaid expenses and other current assets |
8,295 | 6,749 | ||||||
Total current assets |
178,475 | 163,650 | ||||||
Property and equipment net |
40,480 | 31,899 | ||||||
Restricted cash |
5,382 | 8,691 | ||||||
Software development costs net |
5,826 | 3,642 | ||||||
Purchased intangibles net |
19,812 | 12,651 | ||||||
Goodwill |
48,307 | 22,450 | ||||||
Deferred tax assets |
12,148 | 10,959 | ||||||
Investments and other assets |
6,188 | 7,228 | ||||||
Total assets |
$ | 316,618 | $ | 261,170 | ||||
Liabilities & Stockholders Equity |
||||||||
Current liabilities: |
||||||||
Current portion of long-term debt and capital lease obligations |
$ | | $ | 2,909 | ||||
Accounts payable |
3,230 | 559 | ||||||
Accrued compensation |
20,962 | 19,178 | ||||||
Accrued expenses |
15,053 | 10,981 | ||||||
Current portion of deferred revenue |
5,723 | 4,978 | ||||||
Interest rate derivative liability |
| 490 | ||||||
Current portion of deferred rent |
930 | 1,497 | ||||||
Total current liabilities |
45,898 | 40,592 | ||||||
Deferred rent, net of current portion |
3,179 | 5,960 | ||||||
Deferred revenue, net of current portion |
41,975 | 35,661 | ||||||
Other long-term liabilities |
5,550 | 1,897 | ||||||
Debt and capital lease obligations, net of current portion |
| 6,307 | ||||||
Total liabilities |
96,602 | 90,417 | ||||||
Stockholders equity: |
||||||||
Preferred stock, $0.01 par value: 5,000 shares authorized; no shares issued
and outstanding at September 30, 2011 and December 31, 2010, respectively |
| | ||||||
Common stock, $0.01 par value: 125,000 shares authorized; 36,599 shares issued, and 35,322 shares outstanding at September 30, 2011; 35,808 shares issued and 34,530 shares outstanding at December 31, 2010. |
366 | 358 | ||||||
Additional paid-in capital |
236,307 | 200,339 | ||||||
Treasury stock, at cost, 1,278 shares |
(1,200 | ) | (1,200 | ) | ||||
Accumulated other comprehensive (loss) income |
(402 | ) | 28 | |||||
Accumulated deficit |
(15,055 | ) | (28,772 | ) | ||||
Total stockholders equity |
220,016 | 170,753 | ||||||
Total liabilities and stockholders equity |
$ | 316,618 | $ | 261,170 | ||||
5
athenahealth, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except per share amounts)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except per share amounts)
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Revenue: |
||||||||||||||||
Business services |
$ | 80,640 | $ | 61,087 | $ | 223,475 | $ | 170,051 | ||||||||
Implementation and other |
3,100 | 2,056 | 8,080 | 6,121 | ||||||||||||
Total revenue |
83,740 | 63,143 | 231,555 | 176,172 | ||||||||||||
Expense: |
||||||||||||||||
Direct operating |
31,695 | 24,543 | 87,985 | 72,163 | ||||||||||||
Selling and marketing |
20,784 | 13,233 | 56,540 | 37,986 | ||||||||||||
Research and development |
6,141 | 4,645 | 16,386 | 13,543 | ||||||||||||
General and administrative |
11,869 | 10,390 | 35,306 | 33,470 | ||||||||||||
Depreciation and amortization |
4,749 | 2,869 | 11,884 | 7,946 | ||||||||||||
Total expense |
75,238 | 55,680 | 208,101 | 165,108 | ||||||||||||
Operating income |
8,502 | 7,463 | 23,454 | 11,064 | ||||||||||||
Other income (expense): |
||||||||||||||||
Interest income |
84 | 75 | 300 | 219 | ||||||||||||
Interest expense |
(6 | ) | (102 | ) | (237 | ) | (437 | ) | ||||||||
Loss on interest rate derivative contract |
| (111 | ) | (73 | ) | (475 | ) | |||||||||
Other income |
64 | 33 | 108 | 96 | ||||||||||||
Total other income (expense) |
142 | (105 | ) | 98 | (597 | ) | ||||||||||
Income before income taxes |
8,644 | 7,358 | 23,552 | 10,467 | ||||||||||||
Income tax provision |
(3,364 | ) | (3,532 | ) | (9,835 | ) | (5,066 | ) | ||||||||
Net income |
$ | 5,280 | $ | 3,826 | $ | 13,717 | $ | 5,401 | ||||||||
Net income per share Basic |
$ | 0.15 | $ | 0.11 | $ | 0.39 | $ | 0.16 | ||||||||
Net income per share Diluted |
$ | 0.15 | $ | 0.11 | $ | 0.38 | $ | 0.15 | ||||||||
Weighted average shares used
in computing net income per share: |
||||||||||||||||
Basic |
35,155 | 34,174 | 34,934 | 34,101 | ||||||||||||
Diluted |
36,277 | 35,156 | 35,901 | 35,179 |
6
athenahealth, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
Nine Months Ended | ||||||||
September 30, | ||||||||
2011 | 2010 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||
Net income |
$ | 13,717 | $ | 5,401 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
13,353 | 9,325 | ||||||
Amortization of premium on investments |
1,269 | 938 | ||||||
Provision for uncollectible accounts |
649 | 575 | ||||||
Excess tax benefit from stock-based awards |
(10,210 | ) | (5,981 | ) | ||||
Deferred income tax |
(1,931 | ) | (2,334 | ) | ||||
Increase in fair value of contingent consideration |
340 | 304 | ||||||
Stock-based compensation expense |
13,032 | 10,455 | ||||||
Loss on interest rate derivative contract |
73 | 475 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(9,735 | ) | (3,403 | ) | ||||
Prepaid expenses and other current assets |
8,688 | 4,009 | ||||||
Other long-term assets |
335 | (341 | ) | |||||
Accounts payable |
2,383 | (395 | ) | |||||
Accrued expenses |
3,567 | 779 | ||||||
Deferred revenue |
7,059 | 6,452 | ||||||
Deferred rent |
(3,348 | ) | (960 | ) | ||||
Net cash provided by operating activities |
39,241 | 25,299 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||
Capitalized software development costs |
(5,251 | ) | (2,426 | ) | ||||
Purchases of property and equipment |
(9,406 | ) | (14,105 | ) | ||||
Proceeds from sale or disposal of equipment |
| 363 | ||||||
Proceeds from sales and maturities of investments |
124,804 | 78,502 | ||||||
Purchases of short-term and long-term investments |
(97,461 | ) | (102,204 | ) | ||||
Payments for acquisitions |
(34,882 | ) | | |||||
Decrease in restricted cash |
3,309 | 331 | ||||||
Net cash used in investing activities |
(18,887 | ) | (39,539 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||
Proceeds from issuance of common stock under stock plans |
12,826 | 4,440 | ||||||
Excess tax benefit from stock-based awards |
10,210 | 5,981 | ||||||
Payment of contingent consideration accrued at acquisition date |
(2,980 | ) | | |||||
Payment to terminate interest rate derivative contract |
(563 | ) | | |||||
Payments on long-term debt and capital lease obligations |
(9,216 | ) | (2,692 | ) | ||||
Net cash provided by financing activities |
10,277 | 7,729 | ||||||
Effects of exchange rate changes on cash and cash equivalents |
(468 | ) | 39 | |||||
Net increase in cash and cash equivalents |
30,163 | (6,472 | ) | |||||
Cash and cash equivalents at beginning of period |
35,944 | 30,526 | ||||||
Cash and cash equivalents at end of period |
$ | 66,107 | $ | 24,054 | ||||
Supplemental disclosures of non-cash items Property and equipment
recorded in accounts payable and accrued expenses |
$ | 258 | $ | 127 | ||||
Supplemental disclosures Cash paid for interest |
$ | 236 | $ | 437 | ||||
Supplemental disclosures Cash paid for taxes |
$ | 2,164 | $ | 1,465 | ||||
Property and equipment acquired under capital leases |
$ | | $ | 363 | ||||
7
athenahealth, Inc.
STOCK-BASED COMPENSATION EXPENSE
(Unaudited, in thousands)
STOCK-BASED COMPENSATION EXPENSE
(Unaudited, in thousands)
Set forth below is a breakout of stock-based compensation expense for the three and nine
months ended September 30, 2011 and 2010:
Three months ended | Nine months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Stock-based compensation
expense charged to: |
||||||||||||||||
Direct operating |
$ | 810 | $ | 601 | $ | 2,225 | $ | 1,721 | ||||||||
Selling and marketing |
1,842 | 962 | 3,924 | 2,540 | ||||||||||||
Research and development |
480 | 524 | 1,496 | 1,527 | ||||||||||||
General and administrative |
1,984 | 1,674 | 5,387 | 4,667 | ||||||||||||
Total |
$ | 5,116 | $ | 3,761 | $ | 13,032 | $ | 10,455 | ||||||||
athenahealth, Inc.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES
(Unaudited, in thousands, except per share amounts)
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES
(Unaudited, in thousands, except per share amounts)
The following is a reconciliation of the non-GAAP financial measures used by the Company to
describe the Companys financial results determined in accordance with United States generally
accepted accounting principles (GAAP). An explanation of these measures is also included below
under the heading Explanation of Non-GAAP Financial Measures.
While management believes that these non-GAAP financial measures provide useful supplemental
information to investors regarding the underlying performance of the Companys business operations,
investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute
for, financial performance measures prepared in accordance with GAAP. In addition, it should be
noted that these non-GAAP financial measures may be different from non-GAAP measures used by other
companies, and management may utilize other measures to illustrate performance in the future.
Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with
the Companys results of operations as determined in accordance with GAAP.
Please note that these figures may not sum exactly due to rounding.
8
Non-GAAP Adjusted Gross Margin
Set forth below is a presentation of the Companys Non-GAAP Adjusted Gross Profit and
Non-GAAP Adjusted Gross Margin, which represents Non-GAAP Adjusted Gross Profit as a percentage
of total revenue.
(unaudited, in thousands) | Three Months Ended | Nine Months Ended | ||||||||||||||
September 30 | September 30 | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Total revenue |
$ | 83,740 | $ | 63,143 | $ | 231,555 | $ | 176,172 | ||||||||
Direct operating expense |
31,695 | 24,543 | 87,985 | 72,163 | ||||||||||||
Total revenue less direct
operating expense |
52,045 | 38,600 | 143,570 | 104,009 | ||||||||||||
Add: Stock-based compensation expense
allocated to direct operating expense |
810 | 601 | 2,225 | 1,721 | ||||||||||||
Add: Amortization of purchased intangibles |
549 | 460 | 1,469 | 1,380 | ||||||||||||
Non-GAAP Adjusted Gross Profit |
$ | 53,404 | $ | 39,661 | $ | 147,264 | $ | 107,110 | ||||||||
Non-GAAP Adjusted Gross Margin |
63.8 | % | 62.8 | % | 63.6 | % | 60.8 | % |
Non-GAAP Adjusted EBITDA Margin
Set forth below is a reconciliation of the Companys Non-GAAP Adjusted EBITDA and Non-GAAP
Adjusted EBITDA Margin, which represents Non-GAAP Adjusted EBITDA as a percentage of total
revenue.
(unaudited, in thousands) | Three Months Ended | Nine Months Ended | ||||||||||||||
September 30 | September 30 | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Total Revenue |
$ | 83,740 | $ | 63,143 | $ | 231,555 | $ | 176,172 | ||||||||
GAAP net income |
5,280 | 3,826 | 13,717 | 5,401 | ||||||||||||
Add: Provision for income taxes |
3,364 | 3,532 | 9,835 | 5,066 | ||||||||||||
Add: Total other (income) expense |
(142 | ) | 105 | (98 | ) | 597 | ||||||||||
Add: Stock-based compensation expense |
5,116 | 3,761 | 13,032 | 10,455 | ||||||||||||
Add: Depreciation and amortization |
4,749 | 2,869 | 11,884 | 7,946 | ||||||||||||
Add: Amortization of purchased
intangibles |
549 | 460 | 1,469 | 1,380 | ||||||||||||
Non-GAAP Adjusted EBITDA |
$ | 18,916 | $ | 14,553 | $ | 49,839 | $ | 30,845 | ||||||||
Non-GAAP Adjusted EBITDA Margin |
22.6 | % | 23.0 | % | 21.5 | % | 17.5 | % |
9
Non-GAAP Adjusted Operating Income
Set forth below is a reconciliation of the Companys Non-GAAP Adjusted Operating Income and
Non-GAAP Adjusted Operating Income Margin. Non-GAAP Adjusted Operating Income Margin represents
Non-GAAP Adjusted Operating Income as a percentage of total revenue.
(unaudited, in thousands) | Three Months Ended | Nine Months Ended | ||||||||||||||
September 30 | September 30 | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Total revenue |
$ | 83,740 | $ | 63,143 | $ | 231,555 | $ | 176,172 | ||||||||
GAAP net income |
5,280 | 3,826 | 13,717 | 5,401 | ||||||||||||
Add: Provision for income taxes |
3,364 | 3,532 | 9,835 | 5,066 | ||||||||||||
Add: Total other (income) expense |
(142 | ) | 105 | (98 | ) | 597 | ||||||||||
Add: Stock-based compensation expense |
5,116 | 3,761 | 13,032 | 10,455 | ||||||||||||
Add: Amortization of purchased intangibles |
549 | 460 | 1,469 | 1,380 | ||||||||||||
Non-GAAP Adjusted Operating Income |
$ | 14,167 | $ | 11,684 | $ | 37,955 | $ | 22,899 | ||||||||
Non-GAAP Adjusted Operating Income Margin |
16.9 | % | 18.5 | % | 16.4 | % | 13.0 | % |
Non-GAAP Adjusted Net Income
Set forth below is a reconciliation of the Companys Non-GAAP Adjusted Net Income and
Non-GAAP Adjusted Net Income per Diluted Share.
(unaudited, in thousands except per share amounts) | Three Months Ended | Nine Months Ended | ||||||||||||||
September 30 | September 30 | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
GAAP net income |
$ | 5,280 | $ | 3,826 | $ | 13,717 | $ | 5,401 | ||||||||
Add: Loss on interest rate derivative |
| 111 | 73 | 475 | ||||||||||||
Add: Stock-based compensation expense |
5,116 | 3,761 | 13,032 | 10,455 | ||||||||||||
Add: Amortization of purchased intangibles |
549 | 460 | 1,469 | 1,380 | ||||||||||||
Sub-total of tax deductible items |
5,665 | 4,332 | 14,574 | 12,310 | ||||||||||||
(Less): Tax impact of tax deductible items (1) |
(2,266 | ) | (1,733 | ) | (5,830 | ) | (4,924 | ) | ||||||||
Non-GAAP Adjusted Net Income |
$ | 8,679 | $ | 6,425 | $ | 22,461 | $ | 12,787 | ||||||||
Weighted average shares diluted |
36,277 | 35,156 | 35,901 | 35,179 | ||||||||||||
Non-GAAP Adjusted Net Income per Diluted Share |
$ | 0.24 | $ | 0.18 | $ | 0.63 | $ | 0.36 |
(1) | - Tax impact calculated using a statutory tax rate of 40% |
10
(unaudited, in thousands except per share amounts) | Three Months Ended | Nine Months Ended | ||||||||||||||
September 30 | September 30 | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
GAAP net income per share diluted |
$ | 0.15 | $ | 0.11 | $ | 0.38 | $ | 0.15 | ||||||||
Add: Loss on interest rate derivative |
| | | 0.01 | ||||||||||||
Add: Stock-based compensation expense |
0.14 | 0.11 | 0.37 | 0.30 | ||||||||||||
Add: Amortization of purchased intangibles |
0.01 | 0.01 | 0.04 | 0.04 | ||||||||||||
Sub-total of tax deductible items |
0.15 | 0.12 | 0.41 | 0.35 | ||||||||||||
(Less): Tax impact of tax deductible items (1) |
(0.06 | ) | (0.05 | ) | (0.16 | ) | (0.14 | ) | ||||||||
Non-GAAP Adjusted Net Income per Diluted Share |
$ | 0.24 | $ | 0.18 | $ | 0.63 | $ | 0.36 | ||||||||
Weighted average shares diluted |
36,277 | 35,156 | 35,901 | 35,179 |
(1) | - Tax impact calculated using a statutory tax rate of 40% |
athenahealth, Inc.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES FOR FISCAL YEAR 2011 GUIDANCE
(Unaudited, in thousands, except per share amounts)
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES FOR FISCAL YEAR 2011 GUIDANCE
(Unaudited, in thousands, except per share amounts)
Please note that these figures may not sum exactly due to rounding.
Non-GAAP Adjusted Gross Margin Guidance
Set forth below is a presentation of the Companys Non-GAAP Adjusted Gross Profit and Non-GAAP
Adjusted Gross Margin guidance for fiscal year 2011, which represents Non-GAAP Adjusted Gross
Profit as a percentage of total revenue.
LOW | HIGH | |||||||
Fiscal Year Ending December 31, 2011 | ||||||||
Total revenue |
$ | 320.0 | $ | 325.0 | ||||
Direct operating expense |
123.7 | 123.9 | ||||||
Total revenue less direct
operating expense |
$ | 196.3 | $ | 201.1 | ||||
Add:
Stock-based compensation expense allocated to direct operating expense |
3.1 | 3.1 | ||||||
Add: Amortization of purchased intangibles |
2.2 | 2.2 | ||||||
Non-GAAP Adjusted Gross Profit |
$ | 201.6 | $ | 206.4 | ||||
Non-GAAP Adjusted Gross Margin |
63.0 | % | 63.5 | % |
11
Non-GAAP Adjusted EBITDA Guidance
Set forth below is a reconciliation of the Companys Non-GAAP Adjusted EBITDA and Non-GAAP
Adjusted EBITDA Margin guidance for fiscal year 2011, which represents Non-GAAP Adjusted EBITDA as
a percentage of total revenue.
LOW | HIGH | |||||||
Fiscal Year Ending December 31, 2011 | ||||||||
Total Revenue |
$ | 320.0 | $ | 325.0 | ||||
GAAP net income |
15.7 | 18.0 | ||||||
Add: Provision for income taxes |
11.3 | 13.0 | ||||||
Add: Total other (income) expense |
(0.2 | ) | (0.2 | ) | ||||
Add: Stock-based compensation expense |
18.5 | 18.5 | ||||||
Add: Depreciation and amortization |
16.5 | 16.5 | ||||||
Add: Amortization of purchased intangibles |
2.2 | 2.2 | ||||||
Non-GAAP Adjusted EBITDA |
$ | 64.0 | $ | 68.0 | ||||
Non-GAAP Adjusted EBITDA Margin |
20.0 | % | 20.9 | % |
Non-GAAP Adjusted Net Income Guidance
Set forth below is a reconciliation of the Companys Non-GAAP Adjusted Net Income and Non-GAAP
Adjusted Net Income per Diluted Share guidance for fiscal year 2011.
LOW | HIGH | |||||||
Fiscal Year Ending December 31, 2011 | ||||||||
GAAP net income |
$ | 15.7 | $ | 18.0 | ||||
Add: Loss on interest rate derivative contract |
0.1 | 0.1 | ||||||
Add: Stock-based compensation expense |
18.5 | 18.5 | ||||||
Add: Amortization of purchased intangibles |
2.2 | 2.2 | ||||||
Sub-total of tax deductible items |
$ | 20.8 | $ | 20.8 | ||||
(Less): Tax impact of tax deductible items (1) |
(8.3 | ) | (8.3 | ) | ||||
Non-GAAP Adjusted Net Income |
$ | 28.1 | $ | 30.4 | ||||
Non-GAAP Adjusted Net Income per Diluted Share |
$ | 0.78 | $ | 0.85 | ||||
Weighted average shares diluted |
35.9 | 35.9 |
(1) | - Tax impact calculated using statutory tax rate of 40% |
12
LOW | HIGH | |||||||
Fiscal Year Ending December 31, 2011 | ||||||||
GAAP net income per share diluted |
0.44 | 0.50 | ||||||
Add: Loss on interest rate derivative contract |
0.00 | 0.00 | ||||||
Add: Stock-based compensation expense |
0.52 | 0.52 | ||||||
Add: Amortization of purchased intangibles |
0.06 | 0.06 | ||||||
Sub-total of tax deductible items |
$ | 0.58 | $ | 0.58 | ||||
(Less): Tax impact of tax deductible items (1) |
(0.23 | ) | (0.23 | ) | ||||
Non-GAAP Adjusted Net Income per Diluted Share |
$ | 0.78 | $ | 0.85 | ||||
Weighted average shares diluted |
35.9 | 35.9 |
(1) | - Tax impact calculated using statutory tax rate of 40% |
Explanation of Non-GAAP Financial Measures
The Company reports its financial results in accordance with United States generally accepted
accounting principles, or GAAP. However, management believes that in order to properly understand
the Companys short-term and long-term financial and operational trends, investors may wish to
consider the impact of certain non-cash or non-recurring items, when used as a supplement to
financial performance measures in accordance with GAAP. These items result from facts and
circumstances that vary in frequency and/or impact on continuing operations. Management also uses
results of operations before such items to evaluate the operating performance of the Company and
compare it against past periods, make operating decisions, and serve as a basis for strategic
planning. These non-GAAP financial measures provide management with additional means to understand
and evaluate the operating results and trends in the Companys ongoing business by eliminating
certain non-cash expenses and other items that management believes might otherwise make comparisons
of the Companys ongoing business with prior periods more difficult, obscure trends in ongoing
operations, or reduce managements ability to make useful forecasts. Management believes that these
non-GAAP financial measures provide additional means of evaluating period-over-period operating
performance. In addition, management understands that some investors and financial analysts find
this information helpful in analyzing the Companys financial and operational performance and
comparing this performance to its peers and competitors.
Management defines Non-GAAP Adjusted Gross Profit as total revenue, less direct operating
expense, plus stock-based compensation expense allocated to direct operating expense and
amortization of purchased intangibles, and Non-GAAP Adjusted Gross Margin as Non-GAAP Adjusted
Gross Profit as a percentage of total revenue. Management considers these non-GAAP financial
measures to be important indicators of the Companys operational strength and performance of its
business and a good measure of its historical operating trends. Moreover, management believes that
these measures enable investors and financial analysts to closely monitor and understand changes in
the Companys ability to generate income from ongoing business operations.
Management defines Non-GAAP Adjusted EBITDA as the sum of GAAP net income before provision for
income taxes, total other (income) expense, stock-based compensation expense, depreciation and
amortization, and amortization of purchased intangibles and Non-GAAP Adjusted EBITDA Margin as
13
Non-GAAP Adjusted EBITDA as a percentage of total revenue. Management defines Non-GAAP Adjusted
Operating Income as the sum of GAAP net income before provision for income taxes, amortization of
purchased intangibles, total other (income) expense, stock-based compensation expense, and
Non-GAAP Adjusted Operating Income Margin as Non-GAAP Adjusted Operating Income as a percentage
of total revenue. Management defines Non-GAAP Adjusted Net Income as the sum of GAAP net income
before (gain) loss on interest rate derivative contract, stock-based compensation expense,
amortization of purchased intangibles, and any tax impact related to these items, and Non-GAAP
Adjusted Net Income per Diluted Share as Non-GAAP Adjusted Net Income divided by weighted average
diluted shares outstanding. Management considers these non-GAAP financial measures to be important
indicators of the Companys operational strength and performance of its business and a good measure
of its historical operating trends, in particular the extent to which ongoing operations impact the
Companys overall financial performance.
Management excludes each of the items identified below from the applicable non-GAAP financial
measure referenced above for the reasons set forth with respect to that excluded item:
| Stock-based compensation expense excluded because these are non-cash expenses that management does not consider part of ongoing operating results when assessing the performance of the Companys business, and also because the total amount of expense is partially outside of the Companys control because it is based on factors such as stock price, volatility and interest rates, which may be unrelated to our performance during the period in which the expense is incurred. | ||
| Amortization of purchased intangibles purchased intangibles are amortized over a period of several years after an acquisition and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Thus, including such charge does not accurately reflect the performance of the Companys ongoing operations for the period in which such charge is incurred. | ||
| Gains and losses on interest rate derivative contract excluded because until they are realized, to the extent these gains or losses impact a period presented, management does not believe that they reflect the underlying performance of ongoing business operations for such period. |
14